drugset / Trial / NCT03779087

Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection

NCT03779087

Completed 112 enrolled Ping-I (William) Hsu, M.D.
RandomizedParallel-groupOpen-labelTreatment

Summary

From the profiles of antibiotic susceptibility data following eradication therapy, tetracycline, amoxicillin and levofloxacin are all good candidates of antibiotics used in the rescue treatment.

Timeline

Start
2018-07-11
Primary completion
2020-06-30
Completion
2020-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 500 mg
Subject Tetracycline Unknown 500 mg
Background Esomeprazole Small molecule 40 mg
Background Levofloxacin Small molecule 500 mg
Background tripotassium dicitrate bismuthate Unknown 300 mg